Joshua Ismin, Angel Investor

Joshua Ismin is Co‑Founder and CEO of Xylo Bio, developing neuroplastogens—next‑generation therapies to rewire neural circuits and restore brain function in psychiatric and neurological disorders. He is also an active angel investor and LP, backing ventures such as Stockeld Dreamery, Kanna Health, Finless Foods, and Fable Foods, with a focus on biotech, food innovation, and sustainability. Previously, Joshua co‑founded TVN.ASIA (acquired by Tremor Video) and led OutBranch, launching digital platforms across APAC. Earlier, he was General Manager at Microsoft Atlas Asiapac.